Medicine
Neostigmine methylsulfate 10 mg/10 mL injection
Neostigmine methylsulfate 10 mg/10 mL injection is a generic prescription medicine for intravenous use, made by 20 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store in carton until time of use.
Key facts
- Active ingredient (INN)
- Neostigmine methylsulfate
- Brand
- Sold under the generic name
- Strength
- 10 mg/10 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 10 vials of 10 mL, 1 vial of 10 mL, 10 cartons of 10 mL and 28 more
- Manufacturers
- Dr. Reddy's LaboratoriesIndiaAvet PharmaceuticalsIndiaCamber PharmaceuticalsIndiaCaplin SterilesIndiaEugiaIndiaGland PharmaIndiaIndoco RemediesIndiaMedical Purchasing SolutionsFresenius KabiHikma Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store in carton until time of use.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 January 2015
- Identifiers
- RxCUI 311935, 311936DailyMed set ID 7a9d996f-aecb-455f-95fc-1010e461d75d, 28365ed5-8332-48ac-a93d-b165ac3c6eac, d07ff23f-54a5-4036-8005-a3515d4e2194 +25NDC 0641-6149, 0641-6265, 31722-995 +24Application ANDA207042, ANDA212512, ANDA208405 +9
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial in 1 carton / 10 mL in 1 vial | 23155-518-41 | Avet PharmaceuticalsIndia | 25 November 2022 |
| 10 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 31722-995-31 | Camber PharmaceuticalsIndia | 4 January 2021 |
| 10 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 65145-112-10 | Caplin SterilesIndia | 30 April 2021 |
| 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 43598-529-11 | Dr. Reddy's LaboratoriesIndia | 4 September 2018 |
| 10 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 43598-529-36 | Dr. Reddy's LaboratoriesIndia | 4 September 2018 |
| 10 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 55150-349-10 | EugiaIndia | 2 November 2023 |
| 10 carton in 1 carton / 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 68083-384-10 | Gland PharmaIndia | 21 October 2019 |
| 10 carton in 1 package / 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 14445-414-01 | Indoco RemediesIndia | 26 November 2021 |
| 10 vial, multi-dose in 1 tray / 10 mL in 1 vial, multi-dose | 63323-415-10 | Fresenius Kabi | 8 January 2015 |
| 10 vial, multi-dose in 1 tray / 10 mL in 1 vial, multi-dose | 63323-415-36 | Fresenius Kabi | 8 January 2015 |
| 10 vial, multi-dose in 1 tray / 10 mL in 1 vial, multi-dose | 65219-811-10 | Fresenius Kabi | 9 January 2023 |
| 10 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 0641-6149-10 | Hikma Pharmaceuticals | 28 December 2015 |
| 10 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 0641-6265-10 | Hikma Pharmaceuticals | 28 December 2015 |
| 10 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 0641-6277-10 | Hikma Pharmaceuticals | 28 December 2015 |
| 10 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 70121-1479-7 | Amneal Pharmaceuticals | 20 June 2018 |
| 10 carton in 1 package / 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 0548-9602-00 | Amphastar Pharmaceuticals | 25 September 2017 |
| 10 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 71839-106-10 | BE Pharmaceuticals | 17 March 2022 |
| 24 carton in 1 carton / 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 71839-106-24 | BE Pharmaceuticals | 13 May 2019 |
| 10 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 42023-189-10 | Par Health | 26 April 2017 |
| 10 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 70069-806-10 | Somerset Therapeutics | 10 January 2022 |
| 10 vial in 1 carton / 10 mL in 1 vial | 70594-072-02 | Xellia Pharmaceuticals | 11 January 2021 |
| 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 70700-172-22 | Xiromed | 9 September 2020 |
| 10 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 70700-172-23 | Xiromed | 9 September 2020 |
| 1 vial, multi-dose in 1 bag / 10 mL in 1 vial, multi-dose | 71872-7016-1 | Medical Purchasing Solutions | 19 March 2018 |
| 1 carton in 1 bag / 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 71872-7143-1 | Medical Purchasing Solutions | 12 September 2018 |
| 1 vial, multi-dose in 1 bag / 10 mL in 1 vial, multi-dose | 71872-7178-1 | Medical Purchasing Solutions | 12 September 2019 |
| 1 vial, multi-dose in 1 bag / 10 mL in 1 vial, multi-dose | 71872-7271-1 | Medical Purchasing Solutions | 23 September 2022 |
| 1 vial, multi-dose in 1 bag / 10 mL in 1 vial, multi-dose | 71872-7322-1 | Medical Purchasing Solutions | 19 January 2024 |
| 10 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 72572-462-10 | Civica | 16 April 2020 |
| 10 pouch in 1 case / 1 carton in 1 pouch / 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 51662-1557-3 | HealthFirst | 14 June 2021 |
| 10 mL in 1 vial, multi-dose | 84549-172-23 | ProPharma Distribution | 27 August 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 31 May 2013 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Neostigmine methylsulfate
Clinical summary
Neostigmine methylsulfate is a cholinesterase inhibitor indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery. It is available as injection for intravenous use. MedsAcross supplies Neostigmine methylsulfate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Neostigmine methylsulfateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Bloxiverz prescribing information (Exela Pharma Sciences) · U.S. National Library of Medicine, DailyMed
Need Neostigmine methylsulfate 10 mg/10 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.